aod9604 peptide dosing AOD 9604 Dosage Guide: Uses, Timing, and Results AOD-9604 Dosage Chart – 5

Common formulations include: BPC-157: 10 mg per vial in typical KLOW formulations TB-500: 10 mg per vial in typical KLOW formulations GHK-Cu: 50 mg per vial in typical KLOW formulations (highest proportion) KPV: 10 mg per vial in typical KLOW formulations Total blend: 80 mg combined peptide content Individual component research dosing: BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar in cell culture

Titrate: Move to 200 mg per dose (100 units, 1.0 mL) from week 3 onward as tolerated

ACOG states that theoretical concerns regarding the safety of vaccinating lactating individuals do not outweigh the potential benefits of receiving the vaccine

The intramuscular delivery bypasses digestive absorption issues and ensures direct utilization by cells throughout the body

Healthcare providers help tailor a treatment plan to fit your needs

L.WuQ.SongX.XuB.et al (2011)